Go Pro
→ AI billionaires are selling. Quickly. (From The Oxford Club) (Ad)tc pixel Free ANCR Stock Alerts

Animalcare Group (ANCR) Competitors

Animalcare Group logo
GBX 334.80 +1.30 (+0.39%)
As of 07/24/2026 12:25 PM Eastern
Compare

ANCR vs. AMYT, AGY, APH, BXP, and VLG

Should you buy Animalcare Group stock or one of its competitors? MarketBeat compares Animalcare Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Animalcare Group include Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Beximco Pharmaceuticals (BXP), and Venture Life Group (VLG). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Animalcare Group compare to Amryt Pharma?

Animalcare Group (LON:ANCR) and Amryt Pharma (LON:AMYT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

14.3% of Animalcare Group shares are held by institutional investors. 30.1% of Animalcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Animalcare Group's average media sentiment score of 0.00 equaled Amryt Pharma'saverage media sentiment score.

Company Overall Sentiment
Animalcare Group Neutral
Amryt Pharma Neutral

Animalcare Group has a net margin of 5.70% compared to Amryt Pharma's net margin of 0.00%. Animalcare Group's return on equity of 4.46% beat Amryt Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Animalcare Group5.70% 4.46% 2.97%
Amryt Pharma N/A N/A N/A

Animalcare Group has higher earnings, but lower revenue than Amryt Pharma. Amryt Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Animalcare Group£89.11M2.59£36.55M£7.3045.86
Amryt Pharma£210.24M0.00N/A-£33.00N/A

Summary

Animalcare Group beats Amryt Pharma on 7 of the 8 factors compared between the two stocks.

How does Animalcare Group compare to Allergy Therapeutics?

Animalcare Group (LON:ANCR) and Allergy Therapeutics (LON:AGY) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership.

In the previous week, Animalcare Group's average media sentiment score of 0.00 equaled Allergy Therapeutics'average media sentiment score.

Company Overall Sentiment
Animalcare Group Neutral
Allergy Therapeutics Neutral

Animalcare Group has a net margin of 5.70% compared to Allergy Therapeutics' net margin of -85.46%. Allergy Therapeutics' return on equity of 409.00% beat Animalcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Animalcare Group5.70% 4.46% 2.97%
Allergy Therapeutics -85.46%409.00%-34.76%

14.3% of Animalcare Group shares are owned by institutional investors. Comparatively, 0.0% of Allergy Therapeutics shares are owned by institutional investors. 30.1% of Animalcare Group shares are owned by company insiders. Comparatively, 3.6% of Allergy Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Animalcare Group has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market. Comparatively, Allergy Therapeutics has a beta of 0.872, meaning that its stock price is 13% less volatile than the broader market.

Animalcare Group has higher revenue and earnings than Allergy Therapeutics. Allergy Therapeutics is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Animalcare Group£89.11M2.59£36.55M£7.3045.86
Allergy Therapeutics£57.29M6.61-£52.59M-£0.97N/A

Summary

Animalcare Group beats Allergy Therapeutics on 8 of the 11 factors compared between the two stocks.

How does Animalcare Group compare to Alliance Pharma?

Animalcare Group (LON:ANCR) and Alliance Pharma (LON:APH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

In the previous week, Animalcare Group's average media sentiment score of 0.00 equaled Alliance Pharma'saverage media sentiment score.

Company Overall Sentiment
Animalcare Group Neutral
Alliance Pharma Neutral

Animalcare Group has a net margin of 5.70% compared to Alliance Pharma's net margin of -6.00%. Animalcare Group's return on equity of 4.46% beat Alliance Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Animalcare Group5.70% 4.46% 2.97%
Alliance Pharma -6.00%-5.04%5.98%

Animalcare Group has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market. Comparatively, Alliance Pharma has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market.

Animalcare Group has higher earnings, but lower revenue than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Animalcare Group£89.11M2.59£36.55M£7.3045.86
Alliance Pharma£183.50M1.91-£33.65M-£6.20N/A

14.3% of Animalcare Group shares are owned by institutional investors. Comparatively, 66.3% of Alliance Pharma shares are owned by institutional investors. 30.1% of Animalcare Group shares are owned by company insiders. Comparatively, 12.0% of Alliance Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Animalcare Group pays an annual dividend of GBX 5.20 per share and has a dividend yield of 1.6%. Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 3.1%. Animalcare Group pays out 71.2% of its earnings in the form of a dividend. Alliance Pharma pays out -32.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Animalcare Group beats Alliance Pharma on 7 of the 12 factors compared between the two stocks.

How does Animalcare Group compare to Beximco Pharmaceuticals?

Beximco Pharmaceuticals (LON:BXP) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Beximco Pharmaceuticals has a beta of 0.251, indicating that its share price is 75% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Beximco Pharmaceuticals has higher revenue and earnings than Animalcare Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beximco Pharmaceuticals£53.93B0.00£970.84B£1.94 thousand0.03
Animalcare Group£89.11M2.59£36.55M£7.3045.86

0.3% of Beximco Pharmaceuticals shares are owned by institutional investors. Comparatively, 14.3% of Animalcare Group shares are owned by institutional investors. 4.2% of Beximco Pharmaceuticals shares are owned by company insiders. Comparatively, 30.1% of Animalcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than Animalcare Group. MarketBeat recorded 1 mentions for Beximco Pharmaceuticals and 0 mentions for Animalcare Group. Beximco Pharmaceuticals' average media sentiment score of 0.75 beat Animalcare Group's score of 0.00 indicating that Beximco Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Beximco Pharmaceuticals Positive
Animalcare Group Neutral

Beximco Pharmaceuticals has a net margin of 16.76% compared to Animalcare Group's net margin of 5.70%. Beximco Pharmaceuticals' return on equity of 11.99% beat Animalcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Beximco Pharmaceuticals16.76% 11.99% 6.97%
Animalcare Group 5.70%4.46%2.97%

Summary

Beximco Pharmaceuticals beats Animalcare Group on 8 of the 13 factors compared between the two stocks.

How does Animalcare Group compare to Venture Life Group?

Venture Life Group (LON:VLG) and Animalcare Group (LON:ANCR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, valuation, earnings and dividends.

Venture Life Group has a net margin of 17.42% compared to Animalcare Group's net margin of 5.70%. Venture Life Group's return on equity of 7.82% beat Animalcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Venture Life Group17.42% 7.82% 1.56%
Animalcare Group 5.70%4.46%2.97%

21.9% of Venture Life Group shares are owned by institutional investors. Comparatively, 14.3% of Animalcare Group shares are owned by institutional investors. 7.5% of Venture Life Group shares are owned by company insiders. Comparatively, 30.1% of Animalcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Animalcare Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venture Life Group£35.17M2.39£747.21K£4.3715.86
Animalcare Group£89.11M2.59£36.55M£7.3045.86

In the previous week, Venture Life Group's average media sentiment score of 0.75 beat Animalcare Group's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the media.

Company Overall Sentiment
Venture Life Group Positive
Animalcare Group Neutral

Venture Life Group has a beta of 0.217, indicating that its stock price is 78% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

Summary

Animalcare Group beats Venture Life Group on 8 of the 12 factors compared between the two stocks.

Get Animalcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANCR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANCR vs. The Competition

Export
MetricAnimalcare GroupDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£230.27M£5.53B£7.06B£2.64B
Dividend Yield1.56%2.81%2.67%6.15%
P/E Ratio45.865.0827.14368.39
Price / Sales2.591,642.24582.3084,479.14
Price / Cash26.0510.1849.8127.89
Price / Book2.079.9110.287.41
Net Income£36.55M£20.27B£3.60B£5.89B
7 Day Performance0.54%-0.94%-1.27%0.39%
1 Month Performance0.54%-0.16%-1.67%0.27%
1 Year Performance28.21%6.82%18.25%68.12%

Animalcare Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANCR
Animalcare Group
N/AGBX 334.80
+0.4%		N/A+28.2%£230.27M£89.11M45.86220
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24MN/A290
AGY
Allergy Therapeutics
N/AGBX 5.72
+4.0%		N/A-25.3%£362.16M£57.29MN/A612
APH
Alliance Pharma
N/AGBX 64.70
flat		N/AN/A£350.32M£183.50MN/A91,000
BXP
Beximco Pharmaceuticals
N/AGBX 53.96
+1.8%		N/A+35.5%£240.72M£53.93B0.035,500

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:ANCR) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners
The pact that ran the world and dollar just expired
In 1974, a U.S.-Saudi deal tied oil sales exclusively to dollars, forcing nations worldwide to hold dollars an...
Golden Portfolio | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Universal basic income is not impossible. It exist (kind of)
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...
Brownstone Research | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel